| Count |
Word |
| 6.000 |
1 |
| 6.000 |
2 |
| 1.457 |
abnormalities |
| 1.615 |
additional |
| 3.560 |
african-americans |
| 1.514 |
age |
| 4.332 |
ages |
| 3.486 |
alice |
| 1.710 |
analyses |
| 3.582 |
anovulatory |
| 6.000 |
applicant’s |
| 2.500 |
art |
| 3.595 |
artery |
| 2.094 |
associated |
| 1.438 |
association |
| 2.237 |
associations |
| 3.430 |
b-type |
| 1.777 |
biochemical |
| 8.374 |
bnp |
| 5.060 |
cardiovascular |
| 2.337 |
chang |
| 1.744 |
characterization |
| 2.013 |
circulating |
| 0.816 |
clinical |
| 1.780 |
condition |
| 2.845 |
conflicting |
| 2.483 |
contributions |
| 3.497 |
coronary |
| 2.036 |
cross-sectional |
| 1.462 |
current |
|
| Count |
Word |
| 4.353 |
cycles |
| 2.633 |
dallas |
| 2.310 |
data |
| 5.058 |
designed |
| 2.565 |
details |
| 2.199 |
determinants |
| 7.801 |
dhs |
| 0.770 |
diagnosis |
| 1.256 |
differences |
| 2.916 |
disease |
| 3.645 |
estimated |
| 1.823 |
estrogen |
| 1.613 |
evaluate |
| 1.654 |
experience |
| 2.216 |
factors |
| 1.573 |
features |
| 1.238 |
findings |
| 2.942 |
free |
| 2.288 |
fsh |
| 1.313 |
further |
| 2.061 |
gender |
| 2.297 |
generate |
| 2.408 |
genotypes |
| 0.783 |
health |
| 1.036 |
heart |
| 2.329 |
heterogeneous |
| 1.350 |
hormone |
| 1.555 |
hormones |
| 7.409 |
hyperandrogenism |
| 2.511 |
hypotheses |
|
| Count |
Word |
| 1.717 |
hypothesis |
| 1.811 |
improve |
| 1.613 |
improved |
| 1.070 |
increase |
| 2.056 |
indirect |
| 1.363 |
information |
| 1.292 |
insulin |
| 1.897 |
intermediate |
| 1.893 |
levels |
| 1.942 |
lh |
| 1.804 |
linear |
| 1.553 |
lipid |
| 6.844 |
log |
| 1.800 |
measure |
| 1.558 |
measurements |
| 2.384 |
menstrual |
| 1.655 |
metabolic |
| 1.977 |
morphology |
| 1.986 |
mri |
| 3.353 |
multivariable |
| 2.230 |
natriuretic |
| 11.302 |
nt-probnp |
| 1.935 |
obesity |
| 4.769 |
ovarian |
| 5.747 |
over-sampled |
| 14.278 |
pcom |
| 10.202 |
pcos |
| 1.512 |
peptides |
| 1.222 |
performed |
| 4.732 |
phenotypes |
|
| Count |
Word |
| 5.367 |
polycystic |
| 1.201 |
population |
| 2.442 |
preclinical |
| 1.989 |
preliminary |
| 4.827 |
probability-based |
| 2.830 |
proposal |
| 1.428 |
ratio |
| 1.964 |
recognized |
| 1.683 |
regression |
| 1.961 |
regulated |
| 1.501 |
relative |
| 4.004 |
reproductive |
| 1.313 |
resistance |
| 5.974 |
reynolds |
| 2.815 |
risk |
| 2.587 |
serologic |
| 2.834 |
sex |
| 6.469 |
shbg |
| 5.044 |
state-of-the |
| 1.962 |
steroid |
| 1.803 |
strongly |
| 1.291 |
structure |
| 5.633 |
subclinical |
| 2.294 |
subset |
| 1.140 |
syndrome |
| 1.470 |
tested |
| 3.728 |
testosterone |
| 1.152 |
total |
| 2.194 |
transformed |
| 2.074 |
translation |
|
| Count |
Word |
| 0.777 |
treatment |
| 1.789 |
understanding |
| 4.462 |
univariable |
| 3.682 |
women |
| 16.352 |
women’s |
|